CTI BioPharma Corp. (CTIC)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	1,199	763	240	237	92	43
Market Cap Growth	18.67%	218.03%	0.98%	159.24%	115.34%	-63.06%
Enterprise Value	1,256	792	222	189	67	-10
PE Ratio	-16.23	-8.20	-2.45	-4.53	-2.29	-1.45
PS Ratio	15.82	14.14	-	-	27.39	1.62
PB Ratio	-21.84	-43.39	63.66	5.93	3.87	0.73
P/FCF Ratio	-6.73	-9.39	-2.82	-5.62	-3.29	-1.07
P/OCF Ratio	-6.73	-9.39	-2.82	-5.63	-3.29	-1.07
EV/Sales Ratio	16.58	14.68	-	-	20.09	-0.40
EV/EBITDA Ratio	-11.79	-10.16	-2.33	-3.71	-1.75	0.38
EV/EBIT Ratio	-11.32	-9.92	-2.32	-3.67	-1.72	0.37
EV/FCF Ratio	-7.42	-9.75	-2.61	-4.49	-2.42	0.26
Debt / Equity Ratio	-4.59	-6.21	12.58	0.11	0.39	0.24
Debt / EBITDA Ratio	-2.25	-1.40	-0.50	-0.09	-0.24	-0.51
Debt / FCF Ratio	-1.41	-1.34	-0.56	-0.11	-0.33	-0.35
Quick Ratio	1.20	1.17	0.98	3.08	1.82	3.50
Current Ratio	1.27	1.23	1.03	3.19	1.92	3.58
Asset Turnover	0.61	0.42	0	0	0.05	0.26
Interest Coverage	-3.54	-6.08	-39.54	-62.35	-38.94	-23.25
Return on Equity (ROE)	425.90%	550.20%	-298.90%	-122.10%	-109.10%	-43.90%
Return on Assets (ROA)	-55.80%	-72.20%	-133.20%	-73.40%	-64.80%	-29.60%
Return on Capital (ROIC)	-44.80%	-83.00%	1187.00%	-1464.30%	-227.70%	-105.30%
Earnings Yield	-5.78%	-12.19%	-40.83%	-22.09%	-43.69%	-69.11%
FCF Yield	-6.87%	-10.65%	-35.40%	-17.78%	-30.37%	-93.69%
Buyback Yield / Dilution	-31.78%	-27.27%	-26.67%	-22.71%	-3.39%	-53.86%
Total Shareholder Return	-31.78%	-27.27%	-26.67%	-22.71%	-3.39%	-53.86%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).